In a groundbreaking head-to-head trial funded by Eli Lilly, Zepbound outperformed Wegovy in weight loss efficacy. Participants on Zepbound shed…
Browsing: Clinical Updates
Published in JAMA Network Open, the study analyzed data from over 1,200 participants in the Health and Retirement Study. Interestingly,…
A recent study published in The American Journal of Gastroenterology found that televisit care—delivered via phone or video—for patients with…
With endoscopic procedures rising in ambulatory surgery centers (ASCs), gastrointestinal bleeding remains a serious challenge, impacting both patient outcomes and…
A recent UK study in BMC Gastroenterology explored capsule sponge testing as a minimally invasive triage tool for GERD patients,…
Research presented at the 2024 American Foregut Society meeting challenges traditional methods of diagnosing gastroparesis, revealing that most patients diagnosed…
With obesity rates surging, GLP-1 receptor agonists (GLP-1 RAs) are showing promise as effective weight-loss treatments, with significant results for…
Dr. Kyle Staller, a gastroenterologist and neurogastroenterologist at Mass General, unpacks the complexities of IBS-C diagnosis, addressing common misconceptions and…
Interim results from the phase 3 ESSENCE trial reveal that semaglutide, a GLP-1 receptor agonist, is effective in treating metabolic…
Lowering the positivity threshold of a commercial fecal immunochemical test (FIT) can enhance its sensitivity to levels comparable to next-generation…